S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
OTCMKTS:LEAT

Leatt (LEAT) Stock Price, News & Analysis

$8.02
+0.01 (+0.12%)
(As of 04/19/2024 05:38 PM ET)
Today's Range
$8.02
$8.10
50-Day Range
$7.60
$10.50
52-Week Range
$7.05
$16.00
Volume
977 shs
Average Volume
2,327 shs
Market Capitalization
$49.88 million
P/E Ratio
66.84
Dividend Yield
N/A
Price Target
N/A
LEAT stock logo

About Leatt Stock (OTCMKTS:LEAT)

Leatt Corporation designs, develops, markets, and distributes personal protective equipment for participants of motor sports and leisure activities worldwide. The company offers Leatt-Brace system, an injection molded neck protection system designed to prevent injuries to the cervical spine and neck. It also provides helmets for head and brain protection; and body armor products, including chest protectors, full upper body protectors, upper body protection vests, back protectors, knee braces, knee and elbow guards, off-road motorcycle boots, and mountain biking shoes. In addition, the company offers other products, parts, and accessories, such as goggles; toolbelt, duffel, gear, helmet bags, hats, and hydration kits; casual clothing, caps, and sunglasses; and apparel that comprises suits, jackets, jerseys, pants, shorts, socks, and gloves, as well as aftermarket support products. Further, it acts as the original equipment manufacturer for personal protective equipment sold by other brands. The company's products are used by riders of motorcycles, bicycles, snowmobiles, and ATVs. It sells its products to customers through a network of distributors and retailers; and direct to end consumers through digital channels and online store at leatt.com. The company was formerly known as Treadzone, Inc. and changed its name to Leatt Corporation in May 2005. The company was founded in 2001 and is headquartered in Durbanville, South Africa.

LEAT Stock Price History

LEAT Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
See More Headlines
Receive LEAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Leatt and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/13/2024
Today
4/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Leisure
Sub-Industry
N/A
Current Symbol
OTCMKTS:LEAT
CUSIP
522132208
Employees
89
Year Founded
N/A

Profitability

Net Income
$800,000.00
Pretax Margin
2.92%

Debt

Sales & Book Value

Annual Sales
$47.24 million
Cash Flow
$0.32 per share
Book Value
$6.50 per share

Miscellaneous

Free Float
3,820,000
Market Cap
$49.88 million
Optionable
Not Optionable
Beta
1.31
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Dr. Christopher James Leatt ChB (Age 56)
    MB, Founder, Chairman, R&D Consultant and Innovation Officer
    Comp: $599.74k
  • Mr. Sean MacDonald C.A. (Age 47)
    CA (SA), CEO, CFO, President & Director
    Comp: $508.7k
  • Mr. Michael Mason J.D.
    Investor Relations
  • Lara-Jane Pretorius
    Chief Legal & Compliance Officer and Corporate Secretary
  • Mr. Erik Olsson (Age 56)
    International GM & Head of International Distribution

LEAT Stock Analysis - Frequently Asked Questions

How have LEAT shares performed in 2024?

Leatt's stock was trading at $9.55 at the beginning of 2024. Since then, LEAT shares have decreased by 16.0% and is now trading at $8.02.
View the best growth stocks for 2024 here
.

How were Leatt's earnings last quarter?

Leatt Co. (OTCMKTS:LEAT) posted its quarterly earnings data on Wednesday, March, 13th. The company reported ($0.23) EPS for the quarter. The business earned $9.80 million during the quarter. Leatt had a trailing twelve-month return on equity of 1.97% and a net margin of 1.70%.

What other stocks do shareholders of Leatt own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Leatt investors own include FormFactor (FORM), OUTFRONT Media (OUT), Skyworks Solutions (SWKS), Amgen (AMGN), AMCI Acquisition Corp. II (AMCIU), Altius Minerals (ALS), Akamai Technologies (AKAM), Allied Healthcare Products (AHPI) and Allergan (AGN).

How do I buy shares of Leatt?

Shares of LEAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:LEAT) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners